Witnessing heartbreaking experiences of young women with breast cancer drove Professor Francis to lead the world’s biggest trials of hormone treatment options. The global collaboration has demonstrated the value of ovarian suppression treatment, particularly in very young women with high-risk breast cancer. This treatment regime—now being applied in clinics—reduces cancer recurrence and saves lives.
'To see that you can actually impact survival in young women, that is what it’s all about', said Professor Francis.
From our 10 of the Best – sixteenth edition, read about Professor Francis’s dedication and drive to improve outcomes for young women with breast cancer.
10 of the Best is our annual publication, showcasing 10 NHMRC funded health and medical research projects. Explore the other stories from this edition of 10 of the Best.
